Name: #348: Indonesia Town Hall
Start: 2025-06-18T13:45:00-0400
End: 2025-06-18T14:45:00-0400

Wednesday June 18, 2025 1:45pm - 2:45pm EDT

Component Type: Forum
Level: Basic
CE: ACPE 1.00 Knowledge UAN: 0286-0000-25-648-L04-P; CME 1.00; RN 1.00

The Indonesian regulation for clinical research has shown a significant transformation during the past year, after practically being at a very low level for the past decade. The Ministry of Health, together with the Indonesian Drug and Food Regulatory Body are prepared to welcome global pharmaceutical companies to conduct researches in various hospitals in the country.

Learning Objectives

Discuss the recent transformations in Indonesian clinical research regulations and their impact on the country's research environment; Recognize the opportunities and challenges for global pharmaceutical companies conducting clinical research in Indonesia under the new regulatory framework.

Chair

Endang Wahjuningtyas Hoyaranda

Speaker

Indonesia’s Health Research Revolution: Fast-Tracking Innovation & Global Collaboration in Clinical Trials
Budi Gunadi Sadikin

Indonesia’s Regulatory Readiness in Embracing Clinical Trial Transformation
Taruna Ikrar, MD

INA-CRC: The Catalyst of Indonesia’s Clinical Trial Ecosystem Transformation
Indri Rooslamiati Supriadi

Strengthening Indonesia’s Clinical Research Quality: The Critical Role of Clinical Research Unit
Yuli Felistia, MD

Panelist
Ria Siagian

Speakers

Yuli Felistia

Head of Clinical Research Unit, Research Manager, National Brain Center, Mahar Mardjono Hospital, Indonesia

Dr Yuli is a neurologist specializing in neuro-oncology and currently serves as Head of the Clinical Research Unit at the National Brain Center Hospital Mahar Mardjono in Jakarta, Indonesia. She is pursuing a doctoral research program at Universitas Airlangga. She earned her medical... Read More →

Endang Hoyaranda

President, Indonesian Association For the Study of Medicinals (IASMED), Indonesia

Endang is currently the President of the Indonesian Association for the Study of Medicinals, aside from holding her responsibilities as President of Prodia Utama which is the holding company of Prodia Group, a Group of 8 healthcare companies including the largest health laboratory... Read More →

Taruna Ikrar

Chairperson, Indonesia Food and Drug Authority, Indonesia

Prof. dr. Taruna Ikrar, M.D., M.Biomed, Ph.D. Since August 2024, Prof. Ikrar brings exceptional expertise in pharmacology, cardiovascular science, and neuroscience to DIA's Annual Meeting. His remarkable journey spans education at Hasanuddin University, University of Indonesia, and... Read More →

Budi Gunadi Sadikin

Minister, Ministry of Health, Indonesia

Mr. Sadikin was the Vice Minister I of State-owned Enterprises and tasked to establish market leading and globally competitive state-owned enterprises. From July 2020 until December, 22nd 2020, he lead the National Economic Recovery and Transformation Task Force amidst the COVID-19... Read More →

Ria Siagian

Director, Drug Registration Directorate, Indonesia Food and Drug Authority, Indonesia

Indri Supriadi

Director, Center for Biomedical and Health Genomics and INA-CRC, Indonesia Ministry of Health, Indonesia

Indri Rooslamiati Supriadi is Director of Indonesia’s National Center for Biomedical and Health Genomics and the Indonesia Clinical Research Center (INA-CRC) under the Ministry of Health. She leads national efforts in precision medicine and clinical research, streamlining regulations... Read More →

Wednesday June 18, 2025 1:45pm - 2:45pm EDT
150AB Walter E. Washington Convention Center 801 Allen Y. Lew Place, NW Washington, DC 20001-3614 USA

09: Regulatory, Forum

Level Basic
Keyword Global Perspectives
Level Basic
format csv
Credit Type ACPE, CME, RN
Feature Topics Global Perspectives
Tags Forum

Need help? View Support Guides
Event questions? Contact Event Planner

DIA 2025 Global Annual Meeting